PDRX Stock Overview
PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
PD-Rx Pharmaceuticals, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$5.50 |
| 52 Week High | US$7.50 |
| 52 Week Low | US$4.89 |
| Beta | 0 |
| 1 Month Change | 12.02% |
| 3 Month Change | -12.00% |
| 1 Year Change | -8.33% |
| 3 Year Change | 106.77% |
| 5 Year Change | 30.95% |
| Change since IPO | 266.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| PDRX | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 2.4% | -3.7% |
| 1Y | -8.3% | 0.8% | 20.5% |
Return vs Industry: PDRX underperformed the US Healthcare industry which returned -5.2% over the past year.
Return vs Market: PDRX underperformed the US Market which returned 20.9% over the past year.
Price Volatility
| PDRX volatility | |
|---|---|
| PDRX Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PDRX has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PDRX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | n/a | Robert Holsey | www.pdrx.com |
PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company provides approximately 2,600 prepackaged medications; and creams, ointments, ophthalmics, otics, liquids, suspensions, etc. It also offers PD-Rx Net, a web-based application that tracks prescriptions filled at the point of care and print prescription labels for prescription that filled onsite; and manual dispensing system that provides 10 recordkeeping labels to match the 10 bottle trays as a convenient handling package. In addition, the company provides professional assistance by staffed pharmacists and physicians; and pharmaceutical sampling program design to reduce MCO’s pharmaceutical costs, as well as allows medical professionals to offer pre-filled prescriptions to patients free of charge.
PD-Rx Pharmaceuticals, Inc. Fundamentals Summary
| PDRX fundamental statistics | |
|---|---|
| Market cap | US$9.05m |
| Earnings (TTM) | US$3.03m |
| Revenue (TTM) | US$28.72m |
0.0x
P/E Ratio0.0x
P/S RatioIs PDRX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PDRX income statement (TTM) | |
|---|---|
| Revenue | US$28.72m |
| Cost of Revenue | US$17.65m |
| Gross Profit | US$11.06m |
| Other Expenses | US$8.03m |
| Earnings | US$3.03m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did PDRX perform over the long term?
See historical performance and comparison